Odyssey Thera lands $3.5M for matching treatments to diseases

Odyssey Thera, provider of drug discovery tools that determine which medications will be most effective to treat which diseases, has brought in $3.5 million in equity, according to a filing with the SEC. Based in San Ramon, Calif., the company has representatives from Merck, the Burrill Investment Committee and the Brown Foundation Institute for Molecular Medicine on its board of directors.

Next Story: Rummble seeks a location truce as it aggregates check-ins
Previous Story: uTest rates the best TV network web sites, and catches bugs